Newsroom
Latest News
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) released the following statement on the release of Special Counsel Robert Mueller's report:
WASHINGTON, D.C. – A trio of senior U.S. lawmakers, including Rep.
DENVER, CO – U.S. Rep. Diana DeGette (D-CO) said today it's "unacceptable" that the future state of Colorado's economy lies in the hands of one person.
Responding to the dire challenges faced by local news, U.S. representatives are launching bills to protect local news outlets and "to recognize the vital role that local journalists play in promoting good governance and accountability."
WASHINGTON, D.C. – Reps. Diana DeGette (D-CO) and Bill Johnson (R-OH) introduced the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act, yesterday. The bipartisan legislation will improve patient access to podiatrists in Medicaid and improve care for patients with diabetes who need therapeutic shoes via Medicare.
WASHINGTON, D.C. – "The system is broken," U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that's currently investigating the rising cost of insulin, told a panel of drug makers and pharmacy executives who were summoned to appear before Congress today to explain why the cost of the life-saving drug has continued to rise in recent years.
Members of Congress from both parties expressed immense frustration on Wednesday at big increases in insulin prices and vowed to work together on legislation to prevent more people from dying because they could not afford the lifesaving medicine.
U.S. Rep. Diana DeGette threatened pharmaceutical company executives with government intervention Wednesday during a congressional hearing into the rising price of insulin.
"I think we can all agree that the system is broken," DeGette, D-Denver, said about the method the companies use to set their insulin prices.